Systemic lupus erythematosus (SLE)

Version: 3.0
Published: 20 October 2018
Condition for which Ig is not supported.

View Superseded Version  Print
Specific Conditions
  • Systemic lupus erythematosus (SLE)
Level of Evidence Evidence of probable benefit – more research needed (Category 2a)
The use of Ig therapy is not supported in Systemic lupus erythematosus (SLE) because preferable alternative therapies are available for the treatment of this condition.